Today's wire reports out of Switzerland made me chuckle.
Apparently, Jean-Paul Clozel, chief executive of Actelion, told Reuters that "there's been absolutely no offer" to takeover the company.
A cheeky financial blog with stories about deals, dealmakers and anything else I find interesting. Edited by Ben Harrington. [Disclaimer - the information on Betaville does not constitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions.]
Showing posts with label Johnson & Johnson. Show all posts
Showing posts with label Johnson & Johnson. Show all posts
Thursday, 21 April 2016
Thursday, 28 January 2016
More GSK rumours from the Twitterati - part 2
Should I be surprised how these random Twitter rumours get out of control? Probably not.
But there are some readers who are now claiming that little old Betaville is reporting Johnson & Johnson is weighing a bid for GlaxoSmithKline.
But there are some readers who are now claiming that little old Betaville is reporting Johnson & Johnson is weighing a bid for GlaxoSmithKline.
More GSK rumours from the Twitterati
Here's an interesting Tweet from Open Outcrier:
$GSK Hearing vague takeover chatter mentioning JNJ as acquirer. Unconfirmed market chatter.
Subscribe to:
Posts (Atom)